Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | Fund Letter | Travis CockeVoss Value Fund | Cellebrite $CLBT• NASDAQ | Application SoftwareSoftware | Voss Value Fund 2025 Q2 (CLBT) Cellebrite (CLBT), the leading provider of digital forensics software used by law enforcement and government agencies worldwide, reported results that were about as constructive as we could have hoped for given the stock's 50% drop earlier in the year. Management cut revenue... | BULL | View Pitch → |
| Dec 6, 2025 | Fund Letter | Cellebrite $CLBT• NASDAQ | Application SoftwareSoftware | Greenhaven Road Capital 2025 Q2 (CLBT) Cellebrite has been our worst performing holding YTD. Investors are concerned... | BULL | View Pitch → | |
| Dec 4, 2025 | Fund Letter | Eric Mintz, Christopher Sassouni, David CavanaughCarillon Eagle Small Cap Growth Fund | Cellebrite $CLBT• NASDAQ | Application SoftwareSoftware | Carillon Eagle Small Cap Growth Fund 2025 Q2 (CLBT) Cellebrite, which provides software to help law enforcement investigators extract and analyze data from smartphones, provided an outlook that was below expectations, as there were delays in closing deals with government customers, both in the United States and abroad. Despite the temporary... | BULL | View Pitch → |
| Nov 28, 2025 | Fund Letter | Travis CockeVoss Value Fund | Cellebrite $CLBT• NASDAQ | Application SoftwareSoftware | Voss Value Fund 2025 Q3 (CLBT) CLBT is a duopolistic “Rule of 40+” compounder (with a rational private equity owned competitor) trading at a steep discount to software and government intelligence/cybersecurity peers. The set-up in... | BULL | View Pitch → |
| Nov 28, 2025 | Fund Letter | Travis CockeVoss Value Offshore Fund | Cellebrite $CLBT• NASDAQ | Application SoftwareSoftware | Voss Value Offshore Fund 2025 Q3 (CLBT) CLBT is a duopolistic “Rule of 40+” compounder (with a rational private equity owned competitor) trading at a steep discount to software and government intelligence/cybersecurity peers. The set-up in... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.